Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$32.4 - $68.18 $84,078 - $176,927
2,595 New
2,595 $177,000
Q1 2022

May 16, 2022

SELL
$25.68 - $35.59 $107,907 - $149,549
-4,202 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$24.9 - $40.26 $31,125 - $50,325
-1,250 Reduced 22.93%
4,202 $123,000
Q3 2021

Nov 15, 2021

SELL
$25.48 - $37.34 $657,919 - $964,156
-25,821 Reduced 82.57%
5,452 $139,000
Q2 2021

Aug 16, 2021

BUY
$32.46 - $43.42 $815,719 - $1.09 Million
25,130 Added 409.08%
31,273 $1.1 Million
Q1 2021

May 17, 2021

BUY
$38.94 - $50.85 $239,208 - $312,371
6,143 New
6,143 $250,000
Q2 2020

Aug 14, 2020

SELL
$48.73 - $81.82 $17,883 - $30,027
-367 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$41.72 - $87.2 $250 - $523
-6 Reduced 1.61%
367 $19,000
Q4 2019

Feb 14, 2020

BUY
$45.7 - $81.86 $16,543 - $29,633
362 Added 3290.91%
373 $30,000
Q3 2019

Nov 14, 2019

BUY
$45.35 - $57.91 $498 - $637
11 New
11 $1,000
Q4 2018

Feb 14, 2019

SELL
$31.54 - $46.67 $630 - $933
-20 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$38.0 - $51.1 $74,138 - $99,696
-1,951 Reduced 98.99%
20 $1,000
Q2 2018

Aug 14, 2018

BUY
$38.7 - $50.15 $76,277 - $98,845
1,971 New
1,971 $89,000
Q4 2017

Feb 14, 2018

SELL
$29.7 - $45.7 $18,265 - $28,105
-615 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$25.1 - $31.05 $15,436 - $19,095
615
615 $19,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.